|
HU212435B
(en)
|
1990-06-07 |
1996-06-28 |
Sandoz Ag |
Herbicidal compositions containing substituted phthalides and heterocyclic phthalides as active ingredient and process for preparation of their active ingredients.
|
|
AU681419B2
(en)
|
1993-07-09 |
1997-08-28 |
Schering Corporation |
Process for the synthesis of azetidinones
|
|
US5612359A
(en)
|
1994-08-26 |
1997-03-18 |
Bristol-Myers Squibb Company |
Substituted biphenyl isoxazole sulfonamides
|
|
JPH08295646A
(ja)
|
1995-04-26 |
1996-11-12 |
Teijin Ltd |
ビス（ヒドロキシエトキシフェニル）化合物の製造方法
|
|
CN1072649C
(zh)
|
1995-09-13 |
2001-10-10 |
武田药品工业株式会社 |
苯并氧杂吖庚因化合物,其生产方法和用途
|
|
US6187774B1
(en)
|
1996-03-04 |
2001-02-13 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Fused heterocyclic compounds and pharmaceutical applications thereof
|
|
EP1021451A4
(en)
|
1997-01-13 |
2001-02-14 |
Penn State Res Found |
ASYMMETRIC SYNTHESIS AND CATALYSIS USING CHIRAL HETEROCYCLIC COMPOUNDS
|
|
TW536540B
(en)
|
1997-01-30 |
2003-06-11 |
Bristol Myers Squibb Co |
Endothelin antagonists: N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide and N-(4,5-dimethyl-3-isoxazolyl)-2'-[(3,3-dimethyl-2-oxo-1-pyrrolidinyl)methyl]-4'-(2-oxazolyl)[1,1'-biphe
|
|
US6628343B1
(en)
|
1997-05-23 |
2003-09-30 |
Sony Corporation |
Television signal reception circuit, automatic phase shift control circuit and equal amplitude addition circuit
|
|
IT1292461B1
(it)
|
1997-07-03 |
1999-02-08 |
Great Lakes Chemical Italia |
Composti fotocromatici,procedimento per la loro preparazione e loro utilizzo in materiali polimerici
|
|
PT1094816E
(pt)
|
1998-07-06 |
2009-03-10 |
Bristol Myers Squibb Co |
Sulfonamidas bifenílicas duplamente antagonistas receptores de angiotensina e endotelina
|
|
AU5994900A
(en)
|
1999-07-09 |
2001-01-30 |
Isis Innovation Limited |
Compounds for inhibiting diseases and preparing cells for transplantation
|
|
AR035016A1
(es)
|
1999-08-25 |
2004-04-14 |
Takeda Chemical Industries Ltd |
Composicion de azol promotor de produccion/secrecion de neurotrofina, compuesto prodroga del mismo, composicion farmaceutica que lo comprende y uso del mismo para preparar esta ultima.
|
|
PH12000002657B1
(en)
|
1999-10-12 |
2006-02-21 |
Bristol Myers Squibb Co |
C-aryl glucoside SGLT2 inhibitors
|
|
US20030187023A1
(en)
|
2000-07-17 |
2003-10-02 |
Keiji Kubo |
Sulfone derivatives, process for their production and use thereof
|
|
EP1341765A1
(en)
|
2000-12-07 |
2003-09-10 |
AstraZeneca AB |
Therapeutic compounds
|
|
KR20040016828A
(ko)
|
2000-12-08 |
2004-02-25 |
오르토-맥네일 파마슈티칼, 인코퍼레이티드 |
키나제 저해제로서 인다졸릴-치환된 피롤린 화합물
|
|
CA2450555A1
(en)
|
2001-06-25 |
2003-01-03 |
Merck & Co., Inc. |
(pyrimidyl)(phenyl)substituted fused heteroaryl p38 inhibiting and pkg kinase inhibiting compounds
|
|
WO2003064617A2
(en)
|
2002-01-30 |
2003-08-07 |
Montana State University |
Pestalotiopsis microsporia isolates and compounds derived therefrom
|
|
NZ534582A
(en)
|
2002-02-27 |
2006-03-31 |
Pfizer Prod Inc |
ACC inhibitors
|
|
CA2496624A1
(en)
|
2002-09-17 |
2004-04-01 |
Actelion Pharmaceuticals Ltd |
1-pyridin-4-yl-urea derivatives
|
|
EP1556032A1
(en)
|
2002-11-01 |
2005-07-27 |
Takeda Pharmaceutical Company Limited |
Agent for preventing or treating neuropathy
|
|
EP1559422B1
(en)
|
2002-11-08 |
2014-04-30 |
Takeda Pharmaceutical Company Limited |
Receptor function controlling agent
|
|
WO2004048363A1
(ja)
|
2002-11-22 |
2004-06-10 |
Takeda Pharmaceutical Company Limited |
イミダゾール誘導体、その製造法および用途
|
|
WO2004107958A2
(en)
|
2003-05-30 |
2004-12-16 |
Schering Corporation |
Sterol markers as diagnostic tools in the prevention of atherosclerotic diseases and as tools to aid in the selection of agents to be used for the prevention and treatment of atherosclerotic disease
|
|
EP1630152A4
(en)
|
2003-05-30 |
2009-09-23 |
Takeda Pharmaceutical |
CONDENSED CYCLIC COMPOUND
|
|
DE602004019118D1
(de)
|
2003-09-17 |
2009-03-05 |
Janssen Pharmaceutica Nv |
Kondensierte heterocyclische verbindungen als modulatoren des serotoninrezeptors
|
|
US7534887B2
(en)
|
2003-09-30 |
2009-05-19 |
Takeda Pharmaceutical Company Limited |
Thiazoline derivative and use of the same
|
|
EP1695961A4
(en)
|
2003-12-17 |
2007-10-24 |
Takeda Pharmaceutical |
UREA DERIVATIVE, METHOD FOR THE PRODUCTION AND THEIR USE
|
|
JP2007537141A
(ja)
|
2003-12-18 |
2007-12-20 |
ノボ ノルディスク アクティーゼルスカブ |
新規なｇｌｐ−１化合物
|
|
US7544707B2
(en)
|
2003-12-22 |
2009-06-09 |
Eli Lilly And Company |
Bicyclic derivatives as PPAR modulators
|
|
CA2551610A1
(en)
|
2003-12-25 |
2005-07-14 |
Takeda Pharmaceutical Company Limited |
3-(4-benzyloxyphenyl)propanoic acid derivatives
|
|
JP4855777B2
(ja)
|
2003-12-26 |
2012-01-18 |
武田薬品工業株式会社 |
フェニルプロパン酸誘導体
|
|
WO2005087710A1
(ja)
|
2004-03-15 |
2005-09-22 |
Takeda Pharmaceutical Company Limited |
アミノフェニルプロパン酸誘導体
|
|
EP2253315A1
(en)
|
2004-03-30 |
2010-11-24 |
Takeda Pharmaceutical Company Limited |
Alkoxyphenylpropanoic acid derivatives
|
|
EP1751124A4
(en)
|
2004-05-07 |
2010-04-14 |
Exelixis Inc |
RAF MODULATORS AND METHODS OF USE
|
|
TWI396686B
(zh)
|
2004-05-21 |
2013-05-21 |
Takeda Pharmaceutical |
環狀醯胺衍生物、以及其製品和用法
|
|
EA010888B1
(ru)
|
2004-05-25 |
2008-12-30 |
Пфайзер Продактс, Инк. |
Тетраазабензо[е]азуленовые производные и их аналоги
|
|
US7569580B2
(en)
|
2004-06-03 |
2009-08-04 |
Rigel Pharmaceuticals, Inc. |
Heterotricyclic compounds for use as HCV inhibitors
|
|
US20050287100A1
(en)
|
2004-06-08 |
2005-12-29 |
Lebre Caroline |
Cosmetic composition comprising a semi-crystalline polymer and a dispersion of polymer in fatty phase
|
|
GB0419481D0
(en)
|
2004-09-02 |
2004-10-06 |
Cancer Rec Tech Ltd |
Isoindolin-1-one derivatives
|
|
JP2008513512A
(ja)
|
2004-09-21 |
2008-05-01 |
アサーシス， インク． |
Ｃｒｔｈ２受容体拮抗作用を示すインドール酢酸およびこれらの使用
|
|
US20060275288A1
(en)
|
2005-01-20 |
2006-12-07 |
Grihalde Nelson D |
GLP-1 receptor agonist and allosteric modulator monoclonal antibodies and uses thereof
|
|
EP2298295B1
(en)
|
2005-01-31 |
2013-08-28 |
Cephalon, Inc. |
Tumor necrosis factor inhibitors
|
|
TWI372629B
(en)
|
2005-03-18 |
2012-09-21 |
Novo Nordisk As |
Acylated glp-1 compounds
|
|
JP5094394B2
(ja)
|
2005-04-20 |
2012-12-12 |
武田薬品工業株式会社 |
縮合複素環化合物
|
|
EP1907388A1
(en)
|
2005-07-15 |
2008-04-09 |
F. Hoffmann-Roche AG |
Novel heteroaryl fused cyclic amines
|
|
EP1911738A4
(en)
|
2005-07-29 |
2009-12-16 |
Takeda Pharmaceutical |
COMPOUND OF PHENOXYALKANOIC ACID
|
|
EP1916234B1
(en)
|
2005-07-29 |
2014-11-12 |
Takeda Pharmaceutical Company Limited |
Cyclopropanecarboxylic acid compound
|
|
TW200740435A
(en)
|
2005-08-10 |
2007-11-01 |
Takeda Pharmaceuticals Co |
Therapeutic agent for diabetes
|
|
JP2007063225A
(ja)
|
2005-09-01 |
2007-03-15 |
Takeda Chem Ind Ltd |
イミダゾピリジン化合物
|
|
BRPI0618523A2
(pt)
|
2005-11-11 |
2011-09-06 |
Hoffmann La Roche |
compostos de aminas cìclicas fundidas carbocìclicas, composições farmacêuticas e usos dos mesmos
|
|
MX2008010193A
(es)
|
2006-02-10 |
2008-11-27 |
Summit Corp Plc |
Tratamiento de distrofia muscular de duchenne.
|
|
EP2463283B1
(en)
|
2006-04-20 |
2014-06-11 |
Pfizer Products Inc. |
Fused phenyl Amido heterocyclic compounds for the prevention and treatment of glucokinase-mediated diseases
|
|
CL2007001873A1
(es)
|
2006-06-27 |
2008-01-04 |
Takeda Pharmaceutical |
Acido((3s))-6-((¨2,6-dimetil-4-(3-(metilsulfonil)-propoxi)bifenil-3-il)metoxi-2,3-dihidro-1-benzofuran-3-il)acetico o una sal del mismo
|
|
US7919598B2
(en)
|
2006-06-28 |
2011-04-05 |
Bristol-Myers Squibb Company |
Crystal structures of SGLT2 inhibitors and processes for preparing same
|
|
WO2008014219A2
(en)
|
2006-07-24 |
2008-01-31 |
Smithkline Beecham Corporation |
Thiozolidinedione derivatives as p13 kinase inhibitors
|
|
US8492405B2
(en)
|
2006-10-18 |
2013-07-23 |
Takeda Pharmaceutical Company Limited |
Glucokinase-activating fused heterocyclic compounds and methods of treating diabetes and obesity
|
|
UA97257C2
(en)
|
2006-10-19 |
2012-01-25 |
Такеда Фармасьютикал Компани Лимитед |
Indole derivatives
|
|
CA2668491A1
(en)
|
2006-11-03 |
2008-05-08 |
Glenmark Pharmaceuticals S.A. |
Novel cannabinoid receptor ligands, pharmaceutical compositions containing them, and processes for their preparation
|
|
EP2097420B1
(en)
|
2006-11-29 |
2012-04-04 |
Pfizer Products Inc. |
Spiroketone inhibitors of acetyl-coa carboxylase
|
|
JP2010513357A
(ja)
|
2006-12-22 |
2010-04-30 |
ノバルティス アーゲー |
Ｄｐｐ−ｉｖ阻害剤としての１−アミノメチル−１−フェニル−シクロヘキサン誘導体
|
|
JPWO2008093639A1
(ja)
|
2007-01-29 |
2010-05-20 |
武田薬品工業株式会社 |
ピラゾール化合物
|
|
MX2009008103A
(es)
|
2007-02-09 |
2009-08-18 |
Takeda Pharmaceutical |
Compuestos anulares fusionados como agonistas parciales de prar-gamma.
|
|
GB0706072D0
(en)
|
2007-03-28 |
2007-05-09 |
Sterix Ltd |
Compound
|
|
WO2008136428A1
(ja)
|
2007-04-27 |
2008-11-13 |
Takeda Pharmaceutical Company Limited |
含窒素５員複素環化合物
|
|
EP2157859A4
(en)
|
2007-06-19 |
2011-01-12 |
Takeda Pharmaceutical |
INDAZOL COMPOUNDS FOR THE ACTIVATION OF GLUCCOKINASE
|
|
US20090036425A1
(en)
|
2007-08-02 |
2009-02-05 |
Pfizer Inc |
Substituted bicyclolactam compounds
|
|
GB0715087D0
(en)
|
2007-08-03 |
2007-09-12 |
Summit Corp Plc |
Drug combinations for the treatment of duchenne muscular dystrophy
|
|
US20100292292A1
(en)
|
2007-09-13 |
2010-11-18 |
Link Medicine Corporation |
Treatment of Neurodegenerative Diseases Using Indatraline Analogs
|
|
WO2009099736A2
(en)
|
2008-02-06 |
2009-08-13 |
Lead Therapeutics, Inc. |
Benzoxazole carboxamide inhibitors of poly(adp-ribose)polymerase (parp)
|
|
AU2009233711B2
(en)
|
2008-04-09 |
2015-02-12 |
Infinity Pharmaceuticals, Inc |
Inhibitors of fatty acid amide hydrolase
|
|
CA2724603A1
(en)
|
2008-05-28 |
2009-12-03 |
Pfizer Inc. |
Pyrazolospiroketone acetyl-coa carboxylase inhibitors
|
|
WO2009144554A1
(en)
|
2008-05-28 |
2009-12-03 |
Pfizer, Inc. |
Pyrazolospiroketone acetyl-c0a carboxylase inhibitors
|
|
TWI474835B
(zh)
|
2008-06-17 |
2015-03-01 |
Univ Indiana Res & Tech Corp |
用於治療代謝病症及肥胖症之基於ｇｉｐ之混合激動劑
|
|
EP2318370A1
(en)
|
2008-07-29 |
2011-05-11 |
Pfizer Inc. |
Fluorinated heteroaryls
|
|
MX2011002166A
(es)
|
2008-08-28 |
2011-04-07 |
Pfizer |
Derivados de dioxa-biciclo[3.2.1]octano-2,3,1-triol.
|
|
US8735391B2
(en)
|
2008-09-26 |
2014-05-27 |
University Of Kansas |
Synthesis of functionalized octahydro-isoquinolin-1-one-8-carboxamides, octahydro-isoquinolin-1-one-8-carboxylic esters and analogs, and therapeutic methods
|
|
TW201038580A
(en)
|
2009-02-02 |
2010-11-01 |
Pfizer |
4-amino-5-oxo-7,8-dihydropyrimido[5,4-f][1,4]oxazepin-6(5H)-yl)phenyl derivatives
|
|
US8575166B2
(en)
|
2009-02-05 |
2013-11-05 |
Merck Sharp & Dohme Corp. |
Phthalazine-containing antidiabetic compounds
|
|
ES2427279T3
(es)
|
2009-03-11 |
2013-10-29 |
Pfizer Inc. |
Derivados de benzofuranilo usados como inhibidores de glucocinasa
|
|
EP2406230A1
(en)
|
2009-03-11 |
2012-01-18 |
Pfizer Inc. |
Substituted indazole amides and their use as glucokinase activators
|
|
WO2010106457A2
(en)
|
2009-03-20 |
2010-09-23 |
Pfizer Inc. |
3-oxa-7-azabicyclo[3.3.1]nonanes
|
|
JP2012526097A
(ja)
|
2009-05-08 |
2012-10-25 |
ファイザー・インク |
Ｇｐｒ１１９調節因子
|
|
JP2012526096A
(ja)
|
2009-05-08 |
2012-10-25 |
ファイザー・インク |
Ｇｐｒ１１９調節因子
|
|
KR20120061063A
(ko)
|
2009-06-05 |
2012-06-12 |
화이자 인코포레이티드 |
Ｇｐｒ 119 조절제로서의 ｌ-(피페리딘-4-일)-피라졸 유도체
|
|
US20120148586A1
(en)
|
2009-08-27 |
2012-06-14 |
Joyce Ching Tsu Chou |
Glucagon-like protein-1 receptor (glp-1r) agonists for treating autoimmune disorders
|
|
US8455516B2
(en)
|
2010-01-15 |
2013-06-04 |
Touro University |
HIV-1 fusion inhibitors and methods
|
|
US20120021979A1
(en)
|
2010-06-24 |
2012-01-26 |
Vanderbilt University |
GLP-1 receptor modulation of addiction, neuropsychiatric disorders and erectile dysfunction
|
|
HRP20161178T1
(hr)
|
2010-09-30 |
2016-11-04 |
Pfizer Inc. |
N1-PIRAZOLOSPIROKETONSKI INHIBITORI ACETIL-CoA-KARBOKSILAZE
|
|
WO2012065065A1
(en)
|
2010-11-12 |
2012-05-18 |
Follica, Inc. |
Methods and compositions for modulating hair growth, wound healing and scar revision
|
|
JP5805982B2
(ja)
|
2011-04-20 |
2015-11-10 |
ユニチカ株式会社 |
ポリアリレート樹脂フィルムおよび気体分離膜
|
|
JP5687120B2
(ja)
|
2011-04-20 |
2015-03-18 |
ユニチカ株式会社 |
ポリアリレート樹脂
|
|
CN107266558A
(zh)
|
2011-09-06 |
2017-10-20 |
诺沃—诺迪斯克有限公司 |
Glp‑1衍生物
|
|
KR101401705B1
(ko)
|
2012-01-31 |
2014-06-27 |
울산대학교 산학협력단 |
로듐 촉매를 이용한 이소인돌린 유도체의 합성방법
|
|
US20150057243A1
(en)
|
2012-04-02 |
2015-02-26 |
Northern University |
Compositions and Methods for the Inhibition of Methyltransferases
|
|
WO2014055634A1
(en)
|
2012-10-02 |
2014-04-10 |
Yale University |
Identification of small molecule inhibitors of jumonji at-rich interactive domain 1a (jarid1a) and 1b (jarid1b) histone demethylase
|
|
WO2014101120A1
(en)
|
2012-12-28 |
2014-07-03 |
Merck Sharp & Dohme Corp. |
Heterobicyclo-substituted-7-methoxy-[1,2,4]triazolo[1,5-c]quinazolin-5-amine compounds with a2a antagonist properties
|
|
WO2014122067A1
(en)
*
|
2013-02-06 |
2014-08-14 |
Boehringer Ingelheim International Gmbh |
New indanyloxydihydrobenzofuranylacetic acids
|
|
BR112015031040A8
(pt)
|
2013-06-11 |
2018-01-02 |
Receptos Inc |
Novos moduladores do receptor de glp-1
|
|
CN103421006B
(zh)
|
2013-08-18 |
2016-06-22 |
上海师范大学 |
2,3,5,7-四取代二氢吡唑并六氢吡啶衍生物及其制备方法和应用
|
|
EP2857550A1
(en)
|
2013-10-02 |
2015-04-08 |
Basf Se |
Amine precursors for depositing graphene
|
|
US9474755B2
(en)
|
2014-07-25 |
2016-10-25 |
Celgene International Ii Sarl |
GLP-1 receptor modulators
|
|
EP2993174A1
(en)
*
|
2014-09-08 |
2016-03-09 |
Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt GmbH |
Pyrazolopyridine derivatives and their use in therapy
|
|
CN105646459A
(zh)
|
2014-11-13 |
2016-06-08 |
上海和辉光电有限公司 |
一种化合物及其制备方法和应用
|
|
WO2016118639A1
(en)
|
2015-01-20 |
2016-07-28 |
The Trustees Of Columbia University In The City Of New York |
Small molecule oxidizers of pdi and their use
|
|
JP6712323B2
(ja)
|
2015-12-31 |
2020-06-17 |
ハンミ ファーマシューティカル カンパニー リミテッド |
グルカゴン、ｇｌｐ−１及びｇｉｐ受容体のすべてに活性を有する三重活性体
|
|
WO2017182984A1
(en)
|
2016-04-22 |
2017-10-26 |
Sabic Global Technologies B.V. |
Methods of manufacture of 2-aryl-3,3-bis (4-hydroxyaryl) phthalimidines, and polymers derived therefrom
|
|
WO2017182986A1
(en)
|
2016-04-22 |
2017-10-26 |
Sabic Global Technologies B.V. |
Methods of manufacture of 2-aryl-3,3-bis(hydroxyaryl)phthalimidines
|
|
WO2017182983A1
(en)
|
2016-04-22 |
2017-10-26 |
Sabic Global Technologies B.V. |
Methods of manufacture of 2-aryl-3,3-bis(hydroxyaryl)phthalimidines
|
|
AR109179A1
(es)
|
2016-08-19 |
2018-11-07 |
Pfizer |
Inhibidores de diacilglicerol aciltransferasa 2
|
|
JOP20190060A1
(ar)
*
|
2016-09-26 |
2019-03-26 |
Chugai Pharmaceutical Co Ltd |
مشتق بيرازولو بيريدين له تأثير مساعد لمستقبل glp-1
|
|
WO2018106818A1
(en)
|
2016-12-07 |
2018-06-14 |
Kura Oncology, Inc. |
Methods of promoting beta cell proliferation
|
|
CN110325530B
(zh)
|
2016-12-16 |
2022-01-11 |
辉瑞大药厂 |
Glp-1受体激动剂及其用途
|
|
CN120267671A
(zh)
|
2017-03-31 |
2025-07-08 |
奥锐金肿瘤有限公司 |
用于治疗血液病的化合物和组合物
|
|
TWI782056B
(zh)
|
2017-07-14 |
2022-11-01 |
日商鹽野義製藥股份有限公司 |
具有ｍｇａｔ２抑制活性的縮合環衍生物
|
|
JP7461104B2
(ja)
|
2017-11-29 |
2024-04-03 |
中外製薬株式会社 |
Ｇｌｐ－１受容体アゴニスト作用を持つピラゾロピリジン誘導体を含有する医薬組成物
|
|
WO2019126424A1
(en)
|
2017-12-22 |
2019-06-27 |
Chemocentryx, Inc. |
DIARYL SUBSTITUTED 6,5-FUSED RING COMPOUNDS AS C5aR INHIBITORS
|
|
MX2020008126A
(es)
|
2018-02-01 |
2020-09-18 |
Japan Tobacco Inc |
Compuesto de amida heterociclica nitrogenada y su uso para fines medicos.
|
|
WO2019158731A1
(en)
|
2018-02-16 |
2019-08-22 |
Ucb Biopharma Sprl |
Pharmaceutical 6,5 heterobicyclic ring derivatives
|
|
EP3759110A1
(en)
|
2018-02-28 |
2021-01-06 |
Novartis AG |
Indole-2-carbonyl compounds and their use for the treatment of hepatitis b
|
|
US20190284341A1
(en)
|
2018-03-14 |
2019-09-19 |
Sabic Global Technologies B.V. |
3-oxo-2-alkylisoindoline diphthalonitrile monomers, methods of manufacture, thermosetting compositions comprising the same, and uses thereof
|
|
US20190284340A1
(en)
|
2018-03-14 |
2019-09-19 |
SABIC Global Technologies B.V |
3-oxo-2-arylisoindoline diphthalonitrile monomers, methods of manufacture, thermosetting compositions comprising the same, and uses thereof
|
|
ES2993034T3
(en)
*
|
2018-04-02 |
2024-12-20 |
Chemocentryx Inc |
Prodrugs of fused-bicyclic c5ar antagonists
|
|
US10934279B2
(en)
|
2018-06-13 |
2021-03-02 |
Pfizer Inc. |
GLP-1 receptor agonists and uses thereof
|
|
SG11202011704XA
(en)
|
2018-06-15 |
2020-12-30 |
Pfizer |
Glp-1 receptor agonists and uses thereof
|
|
CN112638909A
(zh)
|
2018-06-27 |
2021-04-09 |
香港理工大学 |
具有抗菌活性的化合物
|
|
US11923622B2
(en)
|
2018-08-02 |
2024-03-05 |
Nokia Solutions And Networks Oy |
Antenna and wireless communication device
|
|
BR112021003039A2
(pt)
|
2018-08-31 |
2021-05-18 |
Pfizer Inc. |
combinações para o tratamento de nash/nafld e doenças relacionadas
|
|
UY38436A
(es)
|
2018-11-02 |
2020-05-29 |
Aicuris Gmbh & Co Kg |
Nuevas 6,7-dihidro-4h-pirazolo[1,5-a] pirazinindol-2-carboxamidas activas contra el virus de la hepatitis b (vhb)
|
|
PY1991601A
(es)
|
2018-11-02 |
2020-11-02 |
Aicuris Gmbh & Co Kg |
Nuevas 6,7-dihidro-4h-pirazolo [1,5-a] pirazina indole-2-carboxamidas activas contra el virus de la hepatitis b (vhb)
|
|
CU20210042A7
(es)
|
2018-11-22 |
2022-01-13 |
Qilu Regor Therapeutics Inc |
Compuestos agonistas de glp-1r y composiciones farmacéuticas que lo contienen
|
|
CN111217842B
(zh)
|
2018-11-26 |
2023-01-31 |
上海亚舸生物科技有限公司 |
一类螺环-二吡咯甲烷硼配合物/二吡咯甲川硼配合物及其制备方法和应用
|
|
CN111217796B
(zh)
|
2018-11-26 |
2021-12-14 |
上海亚舸生物科技有限公司 |
一类螺环-二吡咯甲烷/二吡咯甲川化合物及其制备方法和应用
|
|
WO2020117987A1
(en)
|
2018-12-05 |
2020-06-11 |
Viking Therapeutics, Inc. |
Compositions and methods for the treatment of liver disorders
|
|
US20220204473A1
(en)
|
2018-12-25 |
2022-06-30 |
Shanghai Meiyue Biotech Development Co., Ltd. |
Compound as irak inhibitor
|
|
WO2020163236A1
(en)
|
2019-02-04 |
2020-08-13 |
The General Hospital Corporation |
Treating long qt syndrome
|
|
BR112021020335A2
(pt)
|
2019-04-12 |
2021-12-14 |
Qilu Regor Therapeutics Inc |
Agonistas glp-1r e usos dos mesmos
|
|
US12611401B2
(en)
|
2019-05-20 |
2026-04-28 |
Pfizer Inc. |
Combinations comprising benzodioxol as GLP-1R agonists for use in the treatment of NASH/NAFLD and related diseases
|
|
TWI751585B
(zh)
|
2019-06-28 |
2022-01-01 |
美商美國禮來大藥廠 |
類升糖素肽1受體促效劑
|
|
WO2021018023A1
(zh)
|
2019-08-01 |
2021-02-04 |
济南泰达领创医药技术有限公司 |
小分子glp-1受体调节剂
|
|
CN110804059B
(zh)
|
2019-09-30 |
2024-03-12 |
郑州泰基鸿诺医药股份有限公司 |
氨基甲酸酯类化合物、药物组合物及其应用
|
|
PE20221040A1
(es)
|
2019-10-25 |
2022-06-17 |
Gilead Sciences Inc |
Compuestos moduladores de glp-1r
|
|
MA57692B1
(fr)
|
2019-11-15 |
2025-04-30 |
Ildong Pharmaceutical Co., Ltd. |
Agoniste du récepteur glp-1 et son utilisation
|
|
PE20231066A1
(es)
|
2020-02-07 |
2023-07-17 |
Gasherbrum Bio Inc |
Agonistas heterociclicos de glp-1
|
|
JP7836762B2
(ja)
|
2020-02-13 |
2026-03-27 |
ガシャーブラム・バイオ・インコーポレイテッド |
ヘテロ環ｇｌｐ－１アゴニスト
|
|
EP4143183B1
(en)
|
2020-04-29 |
2025-10-22 |
Gasherbrum Bio, Inc. |
Heterocyclic glp-1 agonists
|